Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Silence Therapeutics (SLN)
-
-
-
-
-
-
-
Goldman Sachs Starts Silence Therapeutics (SLN) at Sell
-
-
-
-
-
-
-
Jefferies Starts Silence Therapeutics (SLN) at Buy
-
-
-
-
-
-
-
Silence Therapeutics (SLN) Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran
-
404,920 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

